n.a. (HSP)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)
Hospira Inc. (HSP): Today's Featured Health Care Laggard

Hospira Inc. (HSP): Today's Featured Health Care Laggard

Hospira was a leading decliner within the health care sector, falling $0.39 (-1.1%) to $34.23 on light volume

Hospira Becomes #24 Most Shorted S&P 500 Component, Replacing Leggett & Platt

Hospira Becomes #24 Most Shorted S&P 500 Component, Replacing Leggett & Platt

The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

HSP Makes Bullish Cross Above Critical Moving Average

HSP Makes Bullish Cross Above Critical Moving Average

In trading on Thursday, shares of Hospira Inc crossed above their 200 day moving average of $32.51, changing hands as high as $33.90 per share. Hospira Inc shares are currently trading up about 4.1% on the day.

Hospira Inc. (HSP): Today's Highlighted Laggard In Health Care

Hospira Inc. (HSP): Today's Highlighted Laggard In Health Care

Hospira was a leading decliner within the health care sector, falling 32 cents (-1%) to $30.59 on average volume.

Hospira Inc. (HSP): Today's Featured Drugs Laggard

Hospira Inc. (HSP): Today's Featured Drugs Laggard

Hospira was a leading decliner within the drugs industry, falling 59 cents (-2%) to $29.18 on average volume.

Hospira Rises On Unusually High Volume (HSP)

Hospira Rises On Unusually High Volume (HSP)

Hospira (NYSE:HSP) is trading at unusually high volume Tuesday with 3.9 million shares changing hands. It is currently at 2.1 times its average daily volume and trading up 87 cents (+3%).

Hospira Stock Falls On Unusually High Volume (HSP)

Hospira Stock Falls On Unusually High Volume (HSP)

Hospira (NYSE:HSP) is trading at unusually high volume Wednesday with 3.1 million shares changing hands. It is currently at 2.4 times its average daily volume and trading down 78 cents (-2.2%).

Cramer's 'Mad Money' Recap: The Benefit of Doing Nothing

Cramer's 'Mad Money' Recap: The Benefit of Doing Nothing

Thanks to European and Chinese inaction, American companies have been able to adjust and profit.

Analysts' Actions: TOL PCLN CSCO AFL FRX

Analysts' Actions: TOL PCLN CSCO AFL FRX

Here are today's top research calls.

Hospira Management Discusses Q2 2012 Results - Earnings Call Transcript

Hospira Management Discusses Q2 2012 Results - Earnings Call Transcript

Hospira Management Discusses Q2 2012 Results - Earnings Call Transcript

Hospira's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Hospira's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Hospira's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Hospira Management Discusses Q4 2011 Results - Earnings Call Transcript

Hospira Management Discusses Q4 2011 Results - Earnings Call Transcript

Hospira Management Discusses Q4 2011 Results - Earnings Call Transcript

UBS: 8 Pharma Stocks to Watch

UBS: 8 Pharma Stocks to Watch

UBS Investment Research recently highly these stocks in its review of the pharamaceutical sector.

Analysts' Actions: AEO, NFLX, ARO, YUM, PC

Analysts' Actions: AEO, NFLX, ARO, YUM, PC

Here are today's top research calls.

Hospira Stock Hits New 52-Week Low (HSP)

Hospira Stock Hits New 52-Week Low (HSP)

Hospira (NYSE:HSP) hit a new 52-week low Tuesday as it is currently trading at $27.55, below its previous 52-week low of $28.04 with five million shares traded as of 3:40 p.m. ET. Average volume has been 2.2 million shares over the past 30 days.

Faruqi & Faruqi, LLP Announces Investigation Of Hospira, Inc.

Faruqi & Faruqi, LLP Announces Investigation Of Hospira, Inc.

Faruqi & Faruqi, LLP, a leading national securities firm, is investigating potential securities fraud at Hospira, Inc.

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Hospira, Inc.

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Hospira, Inc.

Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) ( http://www.

Holzer Holzer & Fistel, LLC Announces Investigation Into Hospira, Inc.

Holzer Holzer & Fistel, LLC Announces Investigation Into Hospira, Inc.

Holzer Holzer & Fistel, LLC is investigating potential violations of the federal securities laws by Hospira, Inc.

Hospira's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Hospira's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Hospira's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Hospira Stock Hits New 52-Week Low (HSP)

Hospira Stock Hits New 52-Week Low (HSP)

Hospira (NYSE:HSP) hit a new 52-week low Wednesday as it is currently trading at $29.06, below its previous 52-week low of $34.18 with 1.1 million shares traded as of 10 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.

Hospira Hits 52-Week Low on Slashed Forecast

Hospira Hits 52-Week Low on Slashed Forecast

Hospira shares were falling almost 20% after the drugmaker cut its 2011 earnings forecast.

Hospira Stock Gaps Down On Today's Open (HSP)

Hospira Stock Gaps Down On Today's Open (HSP)

Shares of Hospira (NYSE:HSP) were gapping down Tuesday morning with an open price 18.3% lower than Monday's closing price. The stock closed at $37.36 yesterday and opened today's trading at $30.52.

Hospira Inc. (HSP): Today's Featured Health Care Loser

Hospira Inc. (HSP): Today's Featured Health Care Loser

Hospira Inc was a leading decliner within the health care sector, falling 74 cents (-1.9%) to $38.02 on light volume.

Hospira Inc. Stock Downgraded (HSP)

Hospira Inc. Stock Downgraded (HSP)

Hospira (NYSE:HSP) has been downgraded by TheStreet Ratings from from a buy to hold.

Hewlett-Packard, Texan: Analysts' New Ratings

Hewlett-Packard, Texan: Analysts' New Ratings

Hewlett-Packard downgraded at BMO from Outperform to Market Perform. Texas Instruments downgraded at ThinkEquity from Buy to Hold.

Hospira's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Hospira's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Hospira's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Hospira's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Hospira's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Hospira's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Hospira Inc Stock Upgraded (HSP)

Hospira Inc Stock Upgraded (HSP)

Hospira Inc (NYSE:HSP) has been upgraded by TheStreet Ratings from a hold to buy.

IPO Watch: 2011

IPO Watch: 2011

TheStreet takes a look at the upcoming IPOs of 2011 and their outcomes.